TVTX (TVTX) Stock Price & Analysis
TVTX (TVTX) fell 1.89% to USD 65.28 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
TVTX last closed at USD 65.28; the session ranged USD 65.04–67.11 on volume of 1,050,705 shares. Market capitalization is —, with a 52-week range of USD 20.84–68.03 (NGM). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 65.28 |
|---|---|
| Change | ▼ 1.89% (down) |
| Previous Close | USD 65.28 |
| Open | USD 65.28 |
| Day Range | USD 65.04 – 67.11 |
| 52-Week Range | USD 20.84 – 68.03 |
| Volume | 1,050,705 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TVTX)
Nexqual's technical model rates TVTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.79 (neutral) |
| vs SMA50 | Above (USD 60.26) |
| MACD | 2.03 (positive) |
From TVTX's Latest SEC 10-K Filing (filed 2026-02-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | USD 100.9 | ▲ 1.07% |
| VRDN | Viridian Therapeutics, Inc. | USD 22.92 | ▲ 0.61% |
| ARQT | Arcutis Biotherapeutics, Inc. | USD 23.9 | ▲ 0.21% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.